Not routinely - the last one T1N0 larynx cancer pt I had, I thought about it, but the patient was already 70 without CAD. If I had a 50s year old that had a long development period for carotid atherosclerosis, or somebody with predisposing risk factors for carotid atherosclerosis/stroke I'd have more strongly considered IMRT. I won't begrudge those who consider it routine for every case, however. I just don't think we have any actual proven benefit to carotid sparing, and I'd like to see the data before I make it a routine aspect of clinical practice.
But if I was to do IMRT, I'd still treat the entirety of the larynx to Rx dose. I'm not sure if single cord irradiation is ready for primetime, and don't really want to be an early adopter on something that I don't really know whether it is oncologically safe, especially for something that has such excellent control and minimal toxicity already, where the salvage option is likely a total laryngectomy if not caught super early.